Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma
Clinical trial NCT04910126 · UNKNOWN
Trial details
- NCT number
- NCT04910126
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-12
- Primary completion
- 2023-01-12
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.